Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility

Pigment Cell and Melanoma Research

Volumn 24, Issue 1, 2011, Pages 175-186

  Camilli, Tura C ^a   Xu, Mai ^a   O'Connell, Michael P ^a   Chien, Bonnie ^a   Frank, Brittany P ^a   Subaran, Sarah ^a   Indig, Fred E ^a   Morin, Patrice J ^a   Hewitt, Stephen M ^b   Weeraratna, Ashani T ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Klotho; Melanoma; Sialidase; Syndecan; Wnt5A

Indexed keywords

CALPAIN; FILAMIN; FILAMIN A; KLOTHO PROTEIN; RECOMBINANT KLOTHO PROTEIN; SIALIDASE; SIALIDASE INHIBITOR; SYNDECAN; UNCLASSIFIED DRUG; WNT5A PROTEIN;

ARTICLE; CANCER GROWTH; CANCER INVASION; CELL MOTILITY; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INTERNALIZATION; MELANOMA; MELANOMA CELL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CONTRACTILE PROTEINS; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCURONIDASE; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; MELANOMA; MICE; MICROFILAMENT PROTEINS; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 78651431471     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2010.00792.x     Document Type: Article

References (36)

1. Baudry, M., Dubrin, R., Beasley, L., Leon, M., and Lynch, G. (1986). Low levels of calpain activity in Chiroptera brain: implications for mechanisms of aging. Neurobiol. Aging, 7, 255-258.
2. Besse, S., Delcayre, C., Chevalier, B., Hardouin, S., Heymes, C., Bourgeois, F., Moalic, J.M., and Swynghedauw, B. (1994). Is the senescent heart overloaded and already failing? Cardiovasc. Drugs Ther., 8, 581-587.
3. Blalock, E.M., Porter, N.M., and Landfield, P.W. (1999). Decreased G-protein-mediated regulation and shift in calcium channel types with age in hippocampal cultures. J. Neurosci., 19, 8674-8684.
4. Campisi, J., and D'adda Di Fagagna, F. (2007). Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol., 8, 729-740.
5. Cha, S.K., Ortega, B., Kurosu, H., Rosenblatt, K.P., Kuro, O.M., and Huang, C.L. (2008). Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1. Proc. Natl Acad. Sci. USA, 105, 9805-9810.
6. Chang, Q., Hoefs, S., Van Der Kemp, A.W., Topala, C.N., Bindels, R.J., and Hoenderop, J.G. (2005). The beta-glucuronidase Klotho hydrolyzes and activates the TRPV5 channel. Science, 310, 490-493.
7. Chen, B., Wang, X., Zhao, W., and Wu, J. (2010). Klotho inhibits growth and promotes apoptosis in human lung cancer cell line A549. J Exp Clin Cancer Res, 29, 99.
8. Da Forno, P.D., Pringle, J.H., Hutchinson, P., Osborn, J., Huang, Q., Potter, L., Hancox, R.A., Fletcher, A., and Saldanha, G.S. (2008). WNT5A expression increases during melanoma progression and correlates with outcome. Clin. Cancer Res., 14, 5825-5832.
9. De Oliveira, R.M. (2006). Klotho RNAi induces premature senescence of human cells via a p53/p21 dependent pathway. FEBS Lett., 580, 5753-5758.
10. Dissanayake, S.K., Wade, M., Johnson, C.E. et al. (2007). The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. J. Biol. Chem., 282, 17259-17271.
11. Dissanayake, S.K., Olkhanud, P.B., O'connell, M.P. et al. (2008). Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation. Cancer Res., 68, 10205-10214.
12. Hindson, V.J., Gallagher, J.T., Halfter, W., and Bishop, P.N. (2005). Opticin binds to heparan and chondroitin sulfate proteoglycans. Invest. Ophthalmol. Vis. Sci., 46, 4417-4423.
13. Imura, A., Iwano, A., Tohyama, O., Tsuji, Y., Nozaki, K., Hashimoto, N., Fujimori, T., and Nabeshima, Y. (2004). Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane. FEBS Lett., 565, 143-147.
14. Kuro-O, M., Matsumura, Y., Aizawa, H. et al. (1997). Mutation of the mouse Klotho gene leads to a syndrome resembling ageing. Nature, 390, 45-51.
15. Kurosu, H., Yamamoto, M., Clark, J.D. et al. (2005). Suppression of aging in mice by the hormone Klotho. Science, 309, 1829-1833.
16. Kurosu, H., Ogawa, Y., Miyoshi, M. et al. (2006). Regulation of fibroblast growth factor-23 signaling by Klotho. J. Biol. Chem., 281, 6120-6123.
17. Lachiewicz, A.M., Berwick, M., Wiggins, C.L., and Thomas, N.E. (2008). Epidemiologic support for melanoma heterogeneity using the surveillance, epidemiology, and end results program. J. Invest. Dermatol., 128, 1340-1342.
18. Lee, J., Jeong, D.J., Kim, J. et al. (2010). The anti-aging gene KLOTHO is a novel target for epigenetic silencing in human cervical carcinoma. Mol Cancer, 9, 109.
19. Liu, H., Fergusson, M.M., Castilho, R.M. et al. (2007). Augmented Wnt signaling in a mammalian model of accelerated aging. Science, 317, 803-806.
20. Lynch, C.J., Sobo, G.E., and Exton, J.H. (1986). An endogenous Ca2 + -sensitive proteinase converts the hepatic alpha 1-adrenergic receptor to guanine nucleotide-insensitive forms. Biochim. Biophys. Acta, 885, 110-120.
21. Mammoto, A., Huang, S., and Ingber, D.E. (2007). Filamin links cell shape and cytoskeletal structure to Rho regulation by controlling accumulation of p190RhoGAP in lipid rafts. J. Cell Sci., 120, 456-467.
22. Manya, H., Inomata, M., Fujimori, T., Dohmae, N., Sato, Y., Takio, K., Nabeshima, Y., and Endo, T. (2002). Klotho protein deficiency leads to overactivation of mu-calpain. J. Biol. Chem., 277, 35503-35508.
23. Matsumura, Y., Aizawa, H., Shiraki-Iida, T., Nagai, R., Kuro-O, M., and Nabeshima, Y. (1998). Identification of the human Klotho gene and its two transcripts encoding membrane and secreted Klotho protein. Biochem. Biophys. Res. Commun., 242, 626-630.
24. Miyagi, T., Wada, T., Yamaguchi, K., and Hata, K. (2004). Sialidase and malignancy: a minireview. Glycoconj. J., 20, 189-198.
25. Miyagi, T., Wada, T., Yamaguchi, K., Shiozaki, K., Sato, I., Kakugawa, Y., Yamanami, H., and Fujiya, T. (2008). Human sialidase as a cancer marker. Proteomics, 8, 3303-3311.
26. Nabeshima, Y. (2006). Toward a better understanding of Klotho. Sci Aging Knowledge Environ, 2006, pe11.
27. O'Connell, M.P., Fiori, J.L., Baugher, K.M. et al. (2009a). Wnt5A activates the calpain-mediated cleavage of filamin A. J. Invest. Dermatol., 129, 1782-1789.
28. O'Connell, M.P., Fiori, J.L., Kershner, E.K., Frank, B.P., Indig, F.E., Taub, D.D., Hoek, K.S., and Weeraratna, A.T. (2009b). Heparan sulfate proteoglycan modulation of Wnt5A signal transduction in metastatic melanoma cells. J. Biol. Chem., 284, 28704-28712.
29. Ouanounou, A., Zhang, L., Charlton, M.P., and Carlen, P.L. (1999). Differential modulation of synaptic transmission by calcium chelators in young and aged hippocampal CA1 neurons: evidence for altered calcium homeostasis in aging. J. Neurosci., 19, 906-915.
30. Romero, P.J., Salas, V., and Hernandez, C. (2002). Calcium pump phosphoenzyme from young and old human red cells. Cell Biol. Int., 26, 945-949.
31. Tohyama, O., Imura, A., Iwano, A., Freund, J.N., Henrissat, B., Fujimori, T., and Nabeshima, Y. (2004). Klotho is a novel beta-glucuronidase capable of hydrolyzing steroid beta-glucuronides. J. Biol. Chem., 279, 9777-9784.
32. Uemura, T., Shiozaki, K., Yamaguchi, K., Miyazaki, S., Satomi, S., Kato, K., Sakuraba, H., and Miyagi, T. (2009). Contribution of sialidase NEU1 to suppression of metastasis of human colon cancer cells through desialylation of integrin beta4. Oncogene, 28, 1218-1229.
33. Weeraratna, A.T., Jiang, Y., Hostetter, G., Rosenblatt, K., Duray, P., Bittner, M., and Trent, J.M. (2002). Wnt5A signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell, 1, 279-288.
34. Wolf, I., Levanon-Cohen, S., Bose, S. et al. (2008). Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer. Oncogene, 27, 7094-7105.
35. Woo, M.S., Ohta, Y., Rabinovitz, I., Stossel, T.P., and Blenis, J. (2004). Ribosomal S6 kinase (RSK) regulates phosphorylation of Filamin A on an important regulatory site. Mol. Cell. Biol., 24, 3025-3035.
36. Xiao, N.M., Zhang, Y.M., Zheng, Q., and Gu, J. (2004). Klotho is a serum factor related to human aging. Chin Med J (Engl), 117, 742-747.